Literature DB >> 8482192

Is chemotherapy associated with development of Barrett's esophagus?

F T Peters1, D T Sleijfer, G W van Imhoff, J H Kleibeuker.   

Abstract

Columnar-lined or Barrett's esophagus is a premalignant condition. It is almost unvariably due to chronic gastroesophageal reflux. Since there are some reports that Barrett's esophagus can be induced by chemotherapy, we investigated 20 male patients, treated with chemotherapy for testicular cancer, and 18 female patients, treated with high-dose chemotherapy for breast cancer. Only one patient in the testicular cancer group had Barrett's esophagus of the circumferential type, in addition to typical reflux esophagitis and a hiatal hernia four years after chemotherapy. In the breast cancer group one patient had an indeterminate junction. Our results do not support the hypothesis that chemotherapy poses a substantially increased risk for the development of Barrett's esophagus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482192     DOI: 10.1007/bf01295921

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings.

Authors:  A J Cameron; A R Zinsmeister; D J Ballard; J A Carney
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

2.  Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury?

Authors:  S Sartori; I Nielsen; M Indelli; L Trevisani; P Pazzi; E Grandi
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

Review 3.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus.

Authors:  S J Spechler; E M Schimmel; J W Dalton; W Doos; J S Trier
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

5.  Barrett's esophagus: development of dysplasia and adenocarcinoma.

Authors:  W Hameeteman; G N Tytgat; H J Houthoff; J G van den Tweel
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

6.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

7.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

Authors:  D Machover; E Goldschmidt; P Chollet; G Metzger; J Zittoun; J Marquet; J M Vandenbulcke; J L Misset; L Schwarzenberg; J B Fourtillan
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

9.  Adenocarcinoma in Barrett's oesophagus: an overrated risk.

Authors:  A H Van der Veen; J Dees; J D Blankensteijn; M Van Blankenstein
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

10.  A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett's) esophagus.

Authors:  G M Woolf; R H Riddell; E J Irvine; R H Hunt
Journal:  Gastrointest Endosc       Date:  1989 Nov-Dec       Impact factor: 9.427

View more
  3 in total

1.  Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium.

Authors:  Helen M Shields; Abram Recht; Helen H Wang
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

2.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

3.  Personal and family history of cancer and the risk of Barrett's esophagus in men.

Authors:  N Khalaf; D Ramsey; J R Kramer; H B El-Serag
Journal:  Dis Esophagus       Date:  2014-02-17       Impact factor: 3.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.